Date: April 17, 2012 | 8:30 AM - 5:00 PM
Location: The New York Academy of Sciences, USA
Malaria control options show promise, with effective vaccines in clinical trials, and candidate drugs to address resistance under development. This symposium examines parasite pathogenesis and intervention, and the development of novel therapies. www.nyas.org/Malaria2012
Approximately one half of the world population is at risk in contracting malaria, and it afflicts a disproportionally large number of people in the resource-constrained regions of the world. In recent years there has been a renewed effort in trying to control this disease at different levels, such as basic research of the causative Plasmodium species, new vaccine and drug development programs, efforts to control its vector, mosquito, and improving the public hygiene and the economic status. On the vaccine side, due to the complexity of the parasite physiology and the human immune system, there are many challenges in developing effective vaccines but there are several promising vaccines currently in clinical trials. On the drug side, there are signs of drug-resistance to the current artemisinin-based treatments but there are candidate drugs to address this problem. This symposium will focus on the latest development in our understanding of the parasite, in developing new vaccines, and in discovering potentially novel anti-malarial drugs.